Pink SheetThe US Food and Drug Administration’s July advisory committee schedule includes a curious mix of vaccine safety reviews and the potentially triumphant return of a pulled multiple myeloma drug, in addi
Pink SheetNICE, the health technology assessment (HTA) institute for England, has provisionally recommended that GSK’s Blenrep (belantamab mafodotin) be funded via the National Health Service for use in combina
ScripUCB has become the latest Europe drugmaker to pledge major manufacturing investments in the US amid the pressure being put on the pharmaceutical sector by President Trump administration to move more d